Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression

OBJECTIVE: Type 2 diabetes increases breast cancer risk and mortality, and hyperinsulinemia has been identified as a major factor linking these two diseases. Thus, we hypothesized that pharmacological reduction of elevated insulin levels would attenuate type 2 diabetes–mediated mammary tumor progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Fierz, Yvonne, Novosyadlyy, Ruslan, Vijayakumar, Archana, Yakar, Shoshana, LeRoith, Derek
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828655/
https://www.ncbi.nlm.nih.gov/pubmed/19959755
http://dx.doi.org/10.2337/db09-1291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828655/
https://www.ncbi.nlm.nih.gov/pubmed/19959755
http://dx.doi.org/10.2337/db09-1291

Ejemplares similares